Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Idexx Laboratories (NQ: IDXX )

429.26 +3.15 (+0.74%)
Streaming Delayed Price Updated: 10:59 AM EST, Nov 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Idexx Laboratories

< Previous 1 2 3 4 5 6 7 8 9 Next >
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today. 
Via The Motley Fool
A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback
Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Decoding 5 Analyst Evaluations For IDEXX Laboratories
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
Via Benzinga
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
Idexx Laboratories posted a Q3 EPS of $2.79, beating estimates, though revenue of $975.54 million fell short. Veterinary trends and guidance update key 2024 outlook. 
Via Benzinga
What Analysts Are Saying About IDEXX Laboratories Stock
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today
Via Benzinga
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Via Benzinga
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
Via Benzinga
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
Via Benzinga
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst
Idexx Laboratories reported a 15% rise in Q2 adjusted EPS to $3.02, surpassing the $2.88 consensus. Sales hit $1 billion, up 6%, with Companion Animal Group and Water revenue growth leading. Gross... 
Via Benzinga
IDXX Stock Earnings: IDEXX Laboratories Beats EPS, Beats Revenue for Q2 2024
IDXX stock results show that IDEXX Laboratories beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Analyst Ratings For IDEXX Laboratories
Via Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
Via Benzinga
P/E Ratio Insights for IDEXX Laboratories
Via Benzinga
Looking Into IDEXX Laboratories's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Via Benzinga
7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K
Aggressive investors take note: these seven high-risk. high-reward stocks have the potential to rise in value by as much as 1,000%. 
Via InvestorPlace
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,600 Today
Via Benzinga
How Is The Market Feeling About IDEXX Laboratories?
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $7,500 Today
Via Benzinga
7 Surefire Stocks to Buy Each Time You Get a Paycheck
These seven surefire stocks across diverse sectors offer sticky revenue, consistent performance, and long-term compounding potential. 
Via InvestorPlace
Barking Up the Right Tree: 3 Top Pet Stocks With ‘Pawsitive’ Returns
Investors looking for pet stocks to buy will be barking up the right tree with these companies that sell products for all kinds of animals. 
Via InvestorPlace
$100 Invested In This Stock 15 Years Ago Would Be Worth $2,500 Today
Via Benzinga
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy. 
Via InvestorPlace
Topics ETFs
Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst
IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%. 2024... 
Via Benzinga
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
Despite the post-pandemic slowdown, the pet care industry remains healthy, as these three AI pet stocks to buy now demonstrate. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
IDXX Stock Earnings: IDEXX Laboratories Beats EPS, Misses Revenue for Q1 2024
IDXX stock results show that IDEXX Laboratories beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.